4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062707
Chief Scientific Officer sold 658 shares at $17.90 ($11,778)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Pinkas Jan · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-16 | Sale : show line 1 in the form 10b5-1 | −658 | $17.90 | $11,778 | 21,581 | D |
| Open-market sales · 658 sh · avg $17.90 · $11,778 | ||||||
Loading xslF345X06/wk-form4_1789761795.xml…